PanGenomic Health, Inc. Class A (TSE:NARA) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
PanGenomic Health, a precision health company, is set to file its overdue audited annual financial statements and related documents by June 28, 2024, following a delay caused by payment issues with its auditors. The delay also affected the filing of its interim financial reports, which are expected to be submitted shortly after the annual documents. During this period, the company’s CEOs and CFOs are restricted from trading company securities until the filings are completed and the Management Cease Trade Order by the BCSC is lifted.
For further insights into TSE:NARA stock, check out TipRanks’ Stock Analysis page.
